Synlogic
Cambridge
About Synlogic
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $472.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Sep 2023)
- Ticker: nasdaq:SYBX
- Website: synlogictx.com
- Phone: (617)401-9975
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/synlogic-51995 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.